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A reduction in arterial compliance in patients with
autoimmune diseases such as rheumatoid arthritis and
systemic lupus erythematosus has been previously
reported. It is caused by the effect that systemic inflam-
mation has on the cardiovascular system. Multiple
sclerosis (MS), an immune-mediated disease that exclu-
sively affects the central nervous system (CNS), has a
significant inflammatory component that is limited to
that compartment. The potential effects of its inflamma-
tory mediators in the cardiovascular system are largely
unknown. Purpose: To examine large (C1) and small
arterial compliance (C2) in patients with MS and com-
pare them with healthy age-matched controls. To also
determine whether any differences in C1 and C2 indices
between participants diagnosed with relapsing remitting
MS (RR-MS), secondary progressive MS (SP-MS), and
controls exist. Methods: A total of 26 men and women
between the ages of 18 and 64 diagnosed with MS and
25 healthy controls volunteered for this study. Arterial
compliance was measured by using pulse contour
analysis (PCA), which records and analyzes the blood
pressure waveform data from the Arterial Pulse Wave
Sensors. Results: Significant differences in C1 and C2
were found between young RR-MS and healthy young
controls (P < .05), with the MS group showing lower
arterial C1 and C2 compliance. No significant differ-
ences (P > .05) were seen for C1 or C2 values between
older RR-MS, SP-MS, and healthy controls.Conclusion:
Arterial compliance is significantly compromised in
young individuals withMS, compared with age-matched
controls, but not for older individuals, suggesting a
systemic effect of an inflammatory process that predo-
minantly affects the CNS.
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Introduction
Multiple sclerosis (MS) is a chronic, demyelinating,
inflammatory, immune-mediated disease that affects
the central nervous system (CNS).1 Inflammation is
an independent cardiovascular disease risk factor
that is often associated with endothelial dysfunction2
and loss of arterial compliance in both large and
small arteries.3 The effects that autoimmune
diseases have on the cardiovascular system have
been evaluated before but mainly concentrated on
rheumatoid arthritis (RA) and systemic lupus erythe-
matosus (SLE).4,5 There are few studies done in MS
and those have looked almost exclusively at the auto-
nomic system.6-9 Changes in the peripheral arterial
structure and function, such as thickening of the
vessel wall, decreased small (C2) and large arterial
compliance (C1), and reduction in distensibility of
the large arteries,5 are associated with aging10-12
even in healthy adults,13 more seen in women.14
Arterial compliance is defined as the arteries’ ability
to expand and recoil along with cardiac pulsation and
relaxation.15 A decrease in arterial compliance is
seen with conditions such as diabetes, hypertension,
and hypertriglyceremia.16 Individuals with autoimmune
inflammatory diseases such as RA have documented
reduction in arterial compliance.3 Previous research
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has found that RA is associated with an increase in
arterial stiffness,17 particularly in patients with RAhav-
ing prolonged corticosteroid therapy treatment.18
Rheumatoid arthritis was also associated with earlier
onset of atherosclerosis,19 and disease duration was
correlatedwith the thickness of carotid intima-media.20
To our knowledge, this is the first investigation
that examines C1 and C2 in patients diagnosed with
MS, providing further insight into cardiovascular
parameters associated with this disease. The primary
purpose of this study was to examine C1 and C2 in
patients with MS and compare them with healthy
age-matched controls (C). The secondary purpose
was to investigate whether there were any differences
in C1 and C2 values between patients with relapsing
remitting MS (RR-MS) versus patients with second-
ary progressive MS (SP-MS) and healthy controls.
Our hypotheses were that healthy controls would
have more compliant arteries compared with that of
patients with MS and that patients with RR-MS
would have better arterial compliance compared to
patients with SP-MS.
Methods
Participants
Recruitment. This pilot study involved 51 partici-
pants between the ages of 18 and 64; 25 participants
served as healthy controls and the remaining 26 par-
ticipants had a diagnosis of MS, according to modi-
fied diagnostic McDonald’s criteria.21,22
Participants were required to have relapsing
remitting or secondary progressive MS. None of the
participants were taking hormonal supplements, sta-
tins, or antihypertensive drugs, were current smokers,
were diabetic, and had history of cardiovascular or
peripheral arterial disease (defined by ankle-brachial
index [ABI] index 0.90).23,24 The participants were
volunteers from Mercy Hospital and surrounding
areas of Oklahoma City. All participants gave written
informed consent prior to participation, and all proce-
dures were approved by the Institutional Review
Board at Mercy Hospital.
Research design. This study used a cross-sectional
design with a control group (C, n ¼ 25), a RR-MS
(n¼ 22), and a SP-MS (n¼ 4), and all were assessed
at 1 time point. Age, sex, and cardiovascular disease
risk factors were obtained during medical history
questioning. Height and weight of the participants
were measured from a stadiometer and a scale,
respectively (Detecto scale, MO). Body mass index
(BMI) was calculated as weight (kg)/height (m2).
Blood pressure was measured concurrently with the
large and small arterial indices. To avoid potential
diurnal variations, all patients were tested in a fasted
and rested state in the morning of the visit.
Measurements
Pulse contour analysis. Arterial compliance mea-
surements were obtained in the morning following
an overnight fast of at least 8 hours and prior to enga-
ging in any strenuous physical activity. Following
approximately 10 minutes of rest in the supine posi-
tion, large artery (C1) and small artery (C2) elasticity
indices were obtained using an HDI/Pulsewave
CR-2000 Cardiovascular Profiling System (Hyper-
tension Diagnostic Inc, Eagan, MN). An appropriate-
sized blood pressure cuff was placed around the
participant’s left upper arm, and the right wrist was
placed in a rigid wrist brace to prevent the radial
artery from moving during the measurements. An
Arterial Pulse Wave Sensor was placed on the skin
directly over the radial artery at the point of the
strongest pulse. The sensor was adjusted to the
highest relative signal strength, and the C1 and C2
measures were obtained during 30 seconds of blood
pressure waveform collection. A touch screen com-
puter and software was included in the data collec-
tion. The averages of the three 30-second trials
were used for the analyses after no significant differ-
ences were found between the TRIALS using 1-way
repeated measures analysis of variance (ANOVA).
The measuring tool used (PCA) is a noninvasive
instrument that has been proven to be a reliable tool
for measuring C1 and C2.
Ankle-brachial index. The ABI was assessed using
Doppler ultrasound technique (D.E. Hokanson, Inc,
Bellevue, WA). Participants were examined in the
supine position after a rest of at least 5 minutes.
Systolic blood pressure (SBP) was measured in the
right and left brachial artery by the oscillometric
method and in the posterior tibial and dorsalis pedis
arteries of both legs. The highest brachial systolic
pressure and the artery yielding the highest SBP in
the more diseased limb was used to calculate ABI
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(ABI ¼ ankle systolic pressure/brachial systolic
pressure).24
Statistical Analysis
Descriptive analyses are reported as means + stan-
dard deviation (SD) for the dependent variables.
Independent t tests were used to compare C1 and
C2 for healthy controls and patients with MS.
Analysis of covariance (ANCOVA) was used to
compare C1 and C2 after adjusting for body surface
area. One-way ANOVA was performed to determine
whether any significant difference existed between
the older RR-MS and the older SP-MS group for
C1 and C2 indices. A priori calculation demon-
strated that the current study had an adequate sam-
ple size, based on previous literature17 that obtained
>80% power. These estimates were based on a
population of RA individuals, but used the same
technique. The significance level was P  .05. All
statistical analysis was performed by SPSS 16.0 soft-
ware (Chicago, IL).
Results
There were no significant differences between the
2 young groups for age, height, weight, BMI,
SBP, or diastolic blood pressure (DBP), respectively
(P > .05; Table 1). However, although a significance
(P ¼ .047) was found for BMI between males and
females in the young group with RR-MS, no differ-
ence was found between this group and the young
control group. The males in the RR-MS group had
a significant higher BMI (n ¼ 5, mean ¼ 29.0 +
8.00 [SD]) compared with that of females (n ¼ 4,
mean ¼ 24.8+ 4.50 [SD]).
Young Group’s C1 and C2
Significant differences in C1 and C2 between the 2
young groups (P < .05) were found with theMS group
having decreased C1 (14.8 vs. 19.9 mL/mmHg 10)
and C2 (6.1 vs. 10.5 mL/mm Hg  100) compared
with that of healthy controls (Figures 1 and 2, respec-
tively). After adjusting for body surface area in the
analysis, there still was a significant difference
between the 2 young groups for C1 (P ¼ .038) and
C2 (P ¼ .007) indices.
No differences were found for C1 and C2 indices
between genders for the young RR-MS group. How-
ever, a significant difference was found for C2 only,
Table 1. Clinical Characteristics for Both Young
Groupsa
Variable RR-MS (n ¼ 9) Controls (n ¼ 9)
Age (years) 30.2 (4.49) 34.3 (6.4)
Height (cm) 175.5 (9.9) 173.2 (8.3)
Weight (kg) 79.1 (13.2) 81.2 (19.6)
BMI (kg/m2) 26.4 (4.4) 27.2 (6.6)
SBP (mm Hg) 120.3 (12.9) 127.5 (12.2)
DBP (mm Hg) 69.7 (5.4) 71.8 (8.5)
NOTES: BMI ¼ body mass index; DBP ¼ diastolic blood pres-
sure; RR-MS ¼ relapsing remitting multiple sclerosis; SBP ¼
systolic blood pressure.
a Values are expressed as means (SD). 0
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Figure 1. The C1 values for both young groups. *P < .05.
Values are expressed as means (SE). C1 indicates large arterial
compliance; RR-MS ¼ relapsing remitting multiple sclerosis.
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Figure 2. The C2 values for both young groups. *P < .05.
Values are expressed as means (SE). C2 indicates small arterial
compliance; RR-MS ¼ relapsing remitting multiple sclerosis.
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between males and females for the healthy control
group (P ¼ .049), with men having a lower compli-
ance (n ¼ 13, mean ¼ 9.65 + 1.44) compared to
that of females (n ¼ 14, mean ¼ 9.70 + 2.51), C2
values, respectively.
Older Group’s C1 and C2
No significant differences (P > .05) were observed for
C1 or C2 indices (Figures 3 and 4, respectively), age,
BMI, SBP, or DBP between the older RR-MS and
SP-MS groups compared with healthy controls
(Table 2). Although, not significant, there was a trend
for increased arterial compliance in the healthy older
control group forC1at 17.25 (mL/mmHg 10) versus
older RR-MS at 15.50 (mL/mm Hg  10) and older
SP-MS at 12.36 (mL/mm Hg  10), respectively. The
same was observed for C2, with the control group
showing 7.53 (mL/mm Hg  100) versus RR-MS
5.85 (mL/mm Hg  100) and SP-MS 4.85 (mL/mm
Hg  100), respectively. No gender differences were
found between any of the old groups and BMI, C1,
and C2.
Discussion
We examined C1 and C2 in patients with MS, and
compared them to healthy age-matched controls.
Furthermore, we also wanted to investigate whether
any differences in C1 and C2 values between
patients with RR-MS, patients with SP-MS, and
healthy controls existed. The uniqueness of this
study is that we did demonstrate that arterial compli-
ance is significantly compromised in young individu-
als diagnosed with MS, compared to age-matched
healthy controls, suggesting a potential systemic
effect of an inflammatory process that is primarily
confined to the CNS. This coincides with a study25
reporting altered endothelial function related to
chronic inflammation in young patients with RA that
were free of any cardiovascular risk factors and with
low disease activity. No significant differences were
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Figure 4. The C2 values for all 3 older groups. Values are
expressed as means (SE; P > .05). C2 indicates small arterial
compliance; RR-MS ¼ relapsing remitting multiple sclerosis;
SP-MS ¼ secondary progressive multiple sclerosis.
Table 2. Clinical Characteristics for the 3 Older Groupsa
Variable RR-MS (n ¼ 13) SP-MS (n ¼ 4) Controls (n ¼ 16)
Age (years) 48.8 (6.3) 49.7 (6.6) 48.8 (6.4)
Height (cm) 166.5 (5.5) 159.3 (6.5) 173.7 (9.2)
Weight (kg) 78.6 (15.2) 61.8 (6.9) 90.2 (13.0)
BMI (kg/m2) 28.3 (5.5) 24.2 (1.6) 29.9 (4.2)
SBP (mm Hg) 129.3 (22.8) 139.0 (15.2) 131.7 (17.5)
DBP (mm Hg) 77.4 (13.4) 76.3 (7.5) 77.0 (10.4)
NOTES: BMI ¼ body mass index; DBP ¼ diastolic blood pressure; RR-MS ¼ relapsing remitting multiple sclerosis; SBP ¼ systolic
blood pressure; SP-MS ¼ secondary progressive multiple sclerosis.
a Values are expressed as means (SD).
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Figure 3. The C1 values for all 3 older groups. Values are
expressed as means (SE; P > .05). C1 indicates large arterial
compliance; RR-MS ¼ relapsing remitting multiple sclerosis;
SP-MS ¼ secondary progressive multiple sclerosis.
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observed in SBP and DBP measures between the
2 groups, which are not in agreement with Saari
et al who found significant decrease in blood
pressure in patients with MS compared to healthy
controls.8 Although, not significant, there was a
trend toward better arterial compliance in the
healthy older control group for C1 and C2 compared
to RR-MS and older SP-MS groups (although not
significantly older).
Several studies have previously reported occur-
rence of up to as much as 90% of cardiovascular
autonomic dysfunction in those diagnosed with
MS6-8,26-32 and has been linked to brainstem
lesions,26,31 particularly in the midbrain.8 Other docu-
mented effects include orthostatic intolerance,27,33
disease duration,28 increased Expanded Disability
Status Score,26 progression of clinical disability6,34 as
well as severity of MS.29
The main limitation of this study is the cross-
sectional design, which does not establish a cause
and effect relationship between arterial compliance
and MS. Another limitation is that the PCA is a
noninvasive measure of C1 and C2, and an invasive
measure would be more precise.
Conclusions
This study found significant differences of C1 and
C2 indices between the young healthy group and the
young MS group. This response was not seen in the
older groups and raises awareness of potential risk
for cardiovascular diseases in young adults with
MS who have no other identifiable risk factors.
Future studies are warranted to examine the risk
and development of cardiovascular diseases in the
population with MS. Early identification of such
changes could modify therapies accordingly and
have a significant impact on outcome.
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